Pre-diabetes, metabolic syndrome, and cardiovascular risk

Journal of the American College of Cardiology

Volumn 59, Issue 7, 2012, Pages 635-643

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

cardiovascular prevention; diabetes prevention; metabolic syndrome; pre diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; THIAZIDE DIURETIC AGENT;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INTERMEDIATE HYPERGLYCEMIA; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING TEST; SIDE EFFECT; SYSTEMIC DISEASE; WEIGHT REDUCTION;

EID: 84857022479     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.08.080     Document Type: Review

References (81)

1. A.J. Garber, Y. Handelsman, D. Einhorn Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists Endocr Pract 14 2008 933 946
2. K.G. Alberti Screening and diagnosis of prediabetes: where are we headed? Diabetes Obes Metab 9 Suppl 1 2007 12 16 (Pubitemid 47433964)
3. World Health Organization WHO Expert Committee on Diabetes Mellitus: second report World Health Organ Tech Reo Ser 646 1980 1 80
4. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 28 Suppl 1 2005 s37 s42
5. World Health Organization Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation 2006 World Health Organization Geneva
6. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 3 Suppl 1 2010 S62 S69
7. C.J. Rhodes Type 2 diabetesa matter of beta-cell life and death? Science 307 2005 380 384 (Pubitemid 40139973)
8. S.E. Kahn Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes J Clin Endocrinol Metab 86 2001 4047 4058 (Pubitemid 32848511)
9. E. Ferrannini, A. Gastaldelli, P. Iozzo Pathophysiology of prediabetes Med Clin North Am 95 2011 327 339
10. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 28 1979 1039 1057
11. C.C. Cowie, K.F. Rust, E.S. Ford Full accounting of diabetes and pre-diabetes in the U.S. population in 19881994 and 20052006 Diabetes Care 32 2009 287 294
12. DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts Diabetes Care 26 2003 61 69
13. W.C. Knowler, E. Barrett-Connor, S.E. Fowler Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403 (Pubitemid 34437694)
14. H.C. Gerstein, P. Santaguida, P. Raina Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies Diabetes Res Clin Pract 78 2007 305 312 (Pubitemid 350030320)
15. D.M. Nathan, M.B. Davidson, R.A. DeFronzo American Diabetes Association Impaired fasting glucose and impaired glucose tolerance: implications for care Diabetes Care 30 2007 753 759 (Pubitemid 46354366)
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
17. M.I. Harris, K.M. Flegal, C.C. Cowie Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults The Third National Health and Nutrition Examination Survey, 19881994 Diabetes Care 21 1998 518 524 (Pubitemid 28172927)
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
19. Centers for Disease Control and Prevention National diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007 2008 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA
20. 1c assay in the diagnosis of diabetes Diabetes Care 32 2009 1327 1334
21. 1c national health and nutrition examination survey 20052006 Am J Prev Med 40 2011 11 17
22. S.H. Saydah, D. Byrd-Holt, M.I. Harris Projected impact of implementing the results of the diabetes prevention program in the U.S. population Diabetes Care 25 2002 1940 1945 (Pubitemid 41071048)
23. 1c J Clin Endocrinol Metab 95 2010 5289 5295
24. S.M. Grundy, J.I. Cleeman, S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (erratum in: Circulation 2005;112:e2978) (Pubitemid 41532612)
25. K.G. Alberti, R.H. Eckel, S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
26. Y. Deng, P.E. Scherer Adipokines as novel biomarkers and regulators of the metabolic syndrome Ann N Y Acad Sci 1212 2010 E1 E19
27. G.M. Reaven Insulin resistance, the insulin resistance syndrome, and cardiovascular disease Panminerva Med 47 2005 201 210 (Pubitemid 43471964)
28. A.J. Hanley, L.E. Wagenknecht, R.B. D'Agostino Jr., B. Zinman, S.M. Haffner Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome Diabetes 52 2003 2740 2747 (Pubitemid 37339703)
29. C.M. Alexander, P.B. Landsman, S.M. Grundy Metabolic syndrome and hyperglycemia: congruence and divergence Am J Cardiol 98 2006 982 985 (Pubitemid 44402276)
30. C. Bianchi, R. Miccoli, R.C. Bonadonna GENFIEV Investigators Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study Nutr Metab Cardiovasc Dis 21 2011 699 705
31. M.P. Stern, K. Williams, C. Gonzalez-Villalpando, K.J. Hunt, S.M. Haffner Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681 (Pubitemid 39441469)
32. C. Lorenzo, K. Williams, K.J. Hunt, S.M. Haffner The National Cholesterol Education ProgramAdult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes Diabetes Care 30 2007 8 13 (Pubitemid 46052493)
33. K. Cusi The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes Curr Diab Rep 10 2010 306 315
34. Z. He, G.L. King Microvascular complications of diabetes Endocrinol Metab Clin North Am 33 2004 215 238 xixii (Pubitemid 38438432)
35. W. Bakker, E.C. Eringa, P. Sipkema, V.W. van Hinsbergh Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity Cell Tissue Res 335 2009 165 189
36. G. Tikellis, J.J. Wang, R. Tapp The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study Diabetologia 50 2007 2263 2271 (Pubitemid 47512415)
37. R.J. Tapp, G. Tikellis, T.Y. Wong, C.A. Harper, P.Z. Zimmet, J.E. Shaw Australian Diabetes Obesity and Lifestyle Study Group Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study Diabetes Care 31 2008 1349 1354
38. R.S. Sprague, M.L. Ellsworth Vascular disease in pre-diabetes: new insights derived from systems biology Mo Med 107 2010 265 269
39. J.R. Singleton, A.G. Smith, J.W. Russell, E.L. Feldman Microvascular complications of impaired glucose tolerance Diabetes 52 2003 2867 2873 (Pubitemid 37466854)
40. M.M. Gabir, R.L. Hanson, D. Dabelea Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes Diabetes Care 23 2000 1113 1118 (Pubitemid 30616798)
41. S.C. Satchell, J.E. Tooke What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51 2008 714 725
42. D.K. Singh, P. Winocour, K. Farrington Oxidative stress in early diabetic nephropathy: fueling the fire Nat Rev Endocrinol 7 2011 176 184
43. R.J. Tapp, J.E. Shaw, P.Z. Zimmet Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Am J Kidney Dis 44 2004 792 798 (Pubitemid 39445910)
44. V. Perkovic, C. Verdon, T. Ninomiya The relationship between proteinuria and coronary risk: a systematic review and meta-analysis PLoS Med 5 2008 e207
45. L.C. Plantinga, D.C. Crews, J. Coresh CDC CKD Surveillance Team Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes Clin J Am Soc Nephrol 5 2010 673 682
46. C.S. Fox, M.G. Larson, E.P. Leip, J.B. Meigs, P.W. Wilson, D. Levy Glycemic status and development of kidney disease: the Framingham Heart Study Diabetes Care 28 2005 2436 2440 (Pubitemid 41384290)
47. J.R. Singleton, A.G. Smith Neuropathy associated with prediabetes: what is new in 2007? Curr Diab Rep 7 2007 420 424 (Pubitemid 350284971)
48. A.G. Smith, J.R. Singleton Impaired glucose tolerance and neuropathy Neurologist 14 2008 23 29
49. Y.A. Rajabally Neuropathy and impaired glucose tolerance: an updated review of the evidence Acta Neurol Scand 124 2011 1 8
50. S.H. Horowitz Recent clinical advances in diabetic polyneuropathy Curr Opin Anaesthesiol 19 2006 573 578 (Pubitemid 44386064)
51. G.L. Pittenger, A. Mehrabyan, K. Simmons Small fiber neuropathy is associated with the metabolic syndrome Metab Syndr Relat Disord 3 2005 113 121 (Pubitemid 41269269)
52. N. Kuroda, H. Taniguchi, S. Baba, M. Yamamoto The pupillary light reflex in borderline diabetics J Int Med Res 17 1989 205 211 (Pubitemid 19144759)
53. N. Kuroda, H. Taniguchi, S. Baba, M. Yamamoto Cardiovascular and pupillary light reflexes in subjects with abnormal glucose tolerance Diabetes Res Clin Pract 7 1989 213 218 (Pubitemid 19231483)
54. D. Ziegler, W. Rathmann, T. Dickhaus, C. Meisinger, A. Mielck KORA Study Group Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3 Diabetes Care 31 2008 464 469
55. J.D. Keenan, A.Z. Fan, R. Klein Retinopathy in nondiabetic persons with the metabolic syndrome: findings from the Third National Health and Nutrition Examination Survey Am J Ophthalmol 147 2009 934 944
56. G.E. McVeigh, J.N. Cohn Endothelial dysfunction and the metabolic syndrome Curr Diab Rep 3 2003 87 92 (Pubitemid 38906770)
57. S. Czernichow, J.R. Greenfield, P. Galan Macrovascular and microvascular dysfunction in the metabolic syndrome Hypertens Res 33 2010 293 297
58. R.T. de Jongh, E.H. Sern, R.G. Ijzerman, G. de Vries, C.D. Stehouwer Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance Circulation 109 2004 2529 2535 (Pubitemid 38720552)
59. S.T. Jadhav, W.R. Ferrell, J.R. Petrie Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X Am J Cardiol 97 2006 1727 1731 (Pubitemid 43817858)
60. C.N. Bairey Merz, L.J. Shaw Stable angina in women: lessons from the National Heart, Lung and Blood Institutesponsored Women's Ischemia Syndrome Evaluation J Cardiovasc Med (Hagerstown) 12 2011 85 87
61. J.D. Dean, C.J.H. Jones, S.J. Hutchison, J.R. Peters, A.H. Henderson Hyperinsulinemia and microvascular angina (Syndrome X) Lancet 337 1991 456 457
62. F.Y.L. Li, K.K.Y. Cheng, K.S.L. Lam, P.M. Vanhoutte, A. Xu Cross-talk between adipose tissue and vasculature: role of adiponectin Acta Physiol (Oxf) 203 2011 167 180
63. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, M. Feletou Endothelial dysfunction and vascular disease Acta Physiol (Oxf) 196 2009 193 222
64. A.D. Liese, H.W. Hense, A. Dring, J. Stieber, U. Keil Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95 J Hum Hypertens 15 2001 799 804 (Pubitemid 33054204)
65. Y.I. Kim, C.H. Kim, C.S. Choi Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population Diabetes Res Clin Pract 52 2001 145 152 (Pubitemid 32366484)
66. L. Palaniappan, M. Carnethon, S.P. Fortmann Association between microalbuminuria and the metabolic syndrome: NHANES III Am J Hypertens 16 2003 952 958 (Pubitemid 37315495)
67. A. Chait, K.E. Bornfeldt Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 50 Suppl 2009 S335 S339
68. M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf The relationship between glucose and incident cardiovascular events A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240 (Pubitemid 29056916)
69. R. Huxley, F. Barzi, M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 2006 73 78
70. C.M. Alexander, P.B. Landsman, S.M. Teutsch, S.M. Haffner NHANES III and NCEP Investigators NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 2003 1210 1214 (Pubitemid 36523358)
71. E.S. Ford, G. Zhao, C. Li Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence J Am Coll Cardiol 55 2010 1310 1317
72. W.C. Knowler, R.F. Hamman, S.L. Edelstein DPP Research Group Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program Diabetes 54 2005 1150 1156 (Pubitemid 40446330)
73. J.A. Dormandy, B. Charbonnel, D.J. Eckland PROactive Investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
74. H.C. Gerstein, S. Yusuf, J. Bosch DREAM Trial Investigators Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial Lancet 368 2006 1096 1105
75. E.M. Lonn, H.C. Gerstein, P. Sheridan DREAM (and STARR Investigators Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of atherosclerosis with Ramipril and Rosiglitazone) J Am Coll Cardiol 53 2009 2028 2035
76. S. Kaul, G.A. Diamond Diabetes: breaking news! Rosiglitazone and cardiovascular risk Nat Rev Cardiol 7 2010 670 672
77. E.L. Bierman George Lyman Duff Memorial Lecture Atherogenesis in diabetes Arterioscler Thromb 12 1992 647 656
78. A.S. Gami, B.J. Witt, D.E. Howard Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 2007 403 414 (Pubitemid 46135879)
79. S. Mottillo, K.B. Filion, J. Genest The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
80. W. Zidek, J. Schrader, S. Lders First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation Cardiovasc Diabetol 7 2008 22
81. S. Okada, T. Morimoto, H. Ogawa JPAD Trial Investigators Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetic management: a subanalysis of the JPAD Trial Diabetes Care 34 2011 1277 1283